Side effects of mTOR-inhibiting therapies include severe infections as well as aplasia syndromes like anemia and thrombopenia (137) and metabolic side effects such as hyperlipidemia and hyperglycemia (138). This evidence concerns the gene MTOR and anemia (phenotype).